Evidence map›Paper›PMID 31557992›Full record

ReviewAntibodies (Basel, Switzerland)2016

Generating Recombinant Antibodies to Membrane Proteins through Phage Display.

Renhua Huang, Margaret M Kiss, Melissa Batonick, Michael P Weiner, Brian K Kay

Open access · goldAbstract readReview
In one paragraph

Review in Antibodies (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Renhua HuangDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607-7060, USA. rhuang@meso-scale.com.ORCID 0000-0003-4822-329X
Margaret M KissAxioMx Inc., a subsidiary of Abcam Plc, Branford, CT 06405, USA. margaret.kiss@abcam.com.
Melissa BatonickAxioMx Inc., a subsidiary of Abcam Plc, Branford, CT 06405, USA. melissa.batonick@abcam.com.
Michael P WeinerAxioMx Inc., a subsidiary of Abcam Plc, Branford, CT 06405, USA. michael.weiner@abcam.com.
Brian K KayDepartment of Biological Sciences, University of Illinois at Chicago, Chicago, IL 60607-7060, USA. bkay@uic.edu.
Abcam (United States) · USUniversity of Illinois Chicago · US

Funding

Technology Development for Recombinant Affinity ReagentsU54DK093444 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KAY, BRIAN KENNETH · 2011 to 2013
$3.6M
NIH HHS U54 DK093444
6 · The paper itself

Abstract

One of the most important classes of proteins in terms of drug targets is cell surface membrane proteins, and yet it is a challenging set of proteins for generating high-quality affinity reagents. In this review, we focus on the use of phage libraries, which display antibody fragments, for generating recombinant antibodies to membrane proteins. Such affinity reagents generally have high specificity and affinity for their targets. They have been used for cell staining, for promoting protein crystallization to solve three-dimensional structures, for diagnostics, and for treating diseases as therapeutics. We cover publications on this topic from the past 10 years, with a focus on the various formats of membrane proteins for affinity selection and the diverse affinity selection strategies used. Lastly, we discuss the challenges faced in this field and provide possible directions for future efforts.

Indexed as

affinity selectionfragments of antigen binding (Fabs)G-protein coupled receptors (GPCRs)membrane proteinsnanodiscsphage-displayrecombinant antibodiessingle-domain antibodiestransfectionvirus-like particles (VLPs)

Identifiers

PMID31557992
PMCPMC6698964
OpenAlexW2343946592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.